Genetic Variants Modulating CRIPTO Serum Levels Identified by Genome-Wide Association Study in Cilento Isolates

被引:8
作者
Ruggiero, Daniela [1 ]
Nappo, Stefania [1 ]
Nutile, Teresa [1 ]
Sorice, Rossella [1 ]
Talotta, Francesco [1 ]
Giorgio, Emilia [1 ]
Bellenguez, Celine [2 ,3 ,4 ]
Leutenegger, Anne-Louise [5 ,6 ]
Liguori, Giovanna L. [1 ]
Ciullo, Marina [1 ]
机构
[1] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy
[2] Inst Pasteur, F-59019 Lille, France
[3] INSERM, U744, F-59045 Lille, France
[4] Univ Lille Nord France, Lille, France
[5] INSERM, U946, Paris, France
[6] Univ Paris Diderot, Sorbonne Paris Cite, IUH, UMR S 946, Paris, France
来源
PLOS GENETICS | 2015年 / 11卷 / 01期
关键词
BREAST-CANCER CELLS; TRANSGENIC MICE; MAMMARY-GLAND; COLON-CANCER; MOLECULAR CHARACTERIZATION; SIGNALING PATHWAY; GLP-2; RECEPTOR; STEM-CELLS; TGF-BETA; IN-VIVO;
D O I
10.1371/journal.pgen.1004976
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Cripto, the founding member of the EGF-CFC genes, plays an essential role in embryo development and is involved in cancer progression. Cripto is a GPI-anchored protein that can interact with various components of multiple signaling pathways, such as TGF-beta, Wnt and MAPK, driving different processes, among them epithelial-mesenchymal transition, cell proliferation, and stem cell renewal. Cripto protein can also be cleaved and released outside the cell in a soluble and still active form. Cripto is not significantly expressed in adult somatic tissues and its re-expression has been observed associated to pathological conditions, mainly cancer. Accordingly, CRIPTO has been detected at very low levels in the plasma of healthy volunteers, whereas its levels are significantly higher in patients with breast, colon or glioblastoma tumors. These data suggest that CRIPTO levels in human plasma or serum may have clinical significance. However, very little is known about the variability of serum levels of CRIPTO at a population level and the genetic contribution underlying this variability remains unknown. Here, we report the first genome-wide association study of CRIPTO serum levels in isolated populations (n = 1,054) from Cilento area in South Italy. The most associated SNPs (p-value<5*10-8) were all located on chromosome 3p22.1-3p21.3, in the CRIPTO gene region. Overall six CRIPTO associated loci were replicated in an independent sample (n = 535). Pathway analysis identified a main network including two other genes, besides CRIPTO, in the associated regions, involved in cell movement and proliferation. The replicated loci explain more than 87% of the CRIPTO variance, with 85% explained by the most associated SNP. Moreover, the functional analysis of the main associated locus identified a causal variant in the 5'UTR of CRIPTO gene which is able to strongly modulate CRIPTO expression through an AP-1-mediate transcriptional regulation.
引用
收藏
页数:19
相关论文
共 80 条
  • [31] Gas7b (Growth Arrest Specific Protein 7b) Regulates Neuronal Cell Morphology by Enhancing Microtubule and Actin Filament Assembly
    Gotoh, Aina
    Hidaka, Masafumi
    Hirose, Keiko
    Uchida, Takafumi
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (48) : 34699 - 34706
  • [32] Cripto binds transforming growth factor β (TGF-β) and inhibits TGF-β signaling
    Gray, Peter C.
    Shani, Gidi
    Aung, Kevin
    Kelber, Jonathan
    Vale, Wylie
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (24) : 9268 - 9278
  • [33] Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis
    Gray, Peter C.
    Vale, Wylie
    [J]. FEBS LETTERS, 2012, 586 (14): : 1836 - 1845
  • [34] Tensin1 Requires Protein Phosphatase-1α in Addition to RhoGAP DLC-1 to Control Cell Polarization, Migration, and Invasion
    Hall, Emily H.
    Daugherty, Abbi E.
    Choi, Colin K.
    Horwitz, Alan F.
    Brautigan, David L.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (50) : 34713 - 34722
  • [35] β-catenin/TCF/LEF regulate expression of the short form human Cripto-1
    Hamada, Shin
    Watanabe, Kazuhide
    Hirota, Morihisa
    Bianco, Caterina
    Strizzi, Luigi
    Mancino, Mario
    Gonzales, Monica
    Salomon, David S.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 355 (01) : 240 - 244
  • [36] Germ cell nuclear factor is a repressor of CRIPTO-1 and CRIPTO-3
    Hentschke, Moritz
    Kurth, Ingo
    Borgmeyer, Uwe
    Huebner, Christian A.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (44) : 33497 - 33504
  • [37] Clinicopathological and biological significance of cripto overexpression in human colon cancer
    Jiang, Peng-Cheng
    Zhu, Ling
    Fan, Yu
    Zhao, Hao-Liang
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (46) : 8630 - 8637
  • [38] Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells
    Kajanne, Risto
    Miettinen, Paivi
    Tenhunen, Mikko
    Leppa, Sirpa
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (05) : 1175 - 1182
  • [39] The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition
    Klauzinska, Malgorzata
    Castro, Nadia P.
    Rangel, Maria Cristina
    Spike, Benjamin T.
    Gray, Peter C.
    Bertolette, Daniel
    Cuttitta, Frank
    Salomon, David
    [J]. SEMINARS IN CANCER BIOLOGY, 2014, 29 : 51 - 58
  • [40] Quantitative Real-Time RT-PCR of ITGA7, SVEP1, TNS1, LPHN3, SEMA3G, KLB and MMP13 mRNA Expression in Breast Cancer
    Kotepui, Manas
    Thawornkuno, Charin
    Chavalitshewinkoon-Petmitr, Porntip
    Punyarit, Phaibul
    Petmitr, Songsak
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (11) : 5879 - 5882